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Development/Plasticity/Repair

Overexpression of Sox11 Promotes Corticospinal Tract
Regeneration after Spinal Injury While Interfering with
Functional Recovery
Zimei Wang, Ashley Reynolds, Adam Kirry, Christopher Nienhaus, and Murray G. Blackmore
Department of Biomedical Sciences, Marquette University, Milwaukee, Wisconsin 53201

Embryonic neurons, peripheral neurons, and CNS neurons in zebrafish respond to axon injury by initiating pro-regenerative transcriptional programs that enable axons to extend, locate appropriate targets, and ultimately contribute to behavioral recovery. In contrast,
many long-distance projection neurons in the adult mammalian CNS, notably corticospinal tract (CST) neurons, display a much lower
regenerative capacity. To promote CNS repair, a long-standing goal has been to activate pro-regenerative mechanisms that are normally
missing from injured CNS neurons. Sox11 is a transcription factor whose expression is common to a many types of regenerating neurons,
but it is unknown whether suboptimal Sox11 expression contributes to low regenerative capacity in the adult mammalian CNS. Here we
show in adult mice that dorsal root ganglion neurons (DRGs) and CST neurons fail to upregulate Sox11 after spinal axon injury.
Furthermore, forced viral expression of Sox11 reduces axonal dieback of DRG axons, and promotes CST sprouting and regenerative axon
growth in both acute and chronic injury paradigms. In tests of forelimb dexterity, however, Sox11 overexpression in the cortex caused a
modest but consistent behavioral impairment. These data identify Sox11 as a key transcription factor that can confer an elevated innate
regenerative capacity to CNS neurons. The results also demonstrate an unexpected dissociation between axon growth and behavioral
outcome, highlighting the need for additional strategies to optimize the functional output of stimulated neurons.
Key words: axon regeneration; gene therapy; Sox11; spinal cord injury; transcription factor

Introduction
Recovery from axon injury in the CNS is constrained by the intrinsic inability of many neurons to mount an effective regenerative response (Liu et al., 2011; Blackmore, 2012). In contrast,
embryonic CNS neurons, peripherally injured PNS neurons, and
CNS neurons in anamniotes like zebrafish are capable of reextending severed axons, which then integrate into functional
circuitry and enable remarkable behavioral recovery (Blackmore,
2012; Becker and Becker, 2014). Central to this regenerative success is the initiation of pro-regenerative transcriptional programs
by injured neurons, likely orchestrated by key transcription factors (Smith and Skene, 1997; Veldman et al., 2007). Identifying
and recapitulating these pro-regenerative mechanisms is a longstanding strategy to enhance the regenerative abilities of mammalian CNS neurons. Indeed, forced activation of transcription
factors such as KLF7, STAT3, and SMADs has improved axon
growth in injured CNS neurons (Smith et al., 2009; Parikh et al.,
2011; Blackmore et al., 2012). The evoked regeneration, however,
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falls short of that seen in embryonic, peripheral, or zebrafish
neurons, and the functional contribution of the stimulated
growth remains unclear. Thus, additional factors await discovery
and functional testing.
Sox11, a transcriptional activator, is widely expressed in the
embryonic CNS and PNS during periods of axon growth, and
then is developmentally downregulated (Penzo-Méndez, 2010).
Regeneration-competent neurons such as dorsal root ganglion
(DRG) neurons and zebrafish retinal ganglion cells rapidly
upregulate Sox11 in response to axotomy (Tanabe et al., 2003;
Jankowski et al., 2009). Moreover, knockout of Sox11 interferes with developmental and regenerative PNS axon growth
(Jankowski et al., 2009; Lin et al., 2011; Shim et al., 2012a). It
remains unclear, however, whether forced Sox11 expression
might be sufficient to promote axon growth and functional
recovery after CNS injury. Here we show that virus-mediated
expression of Sox11 reduces retraction in centrally injured
DRG axons, and in corticospinal tract (CST) neurons it promotes both compensatory sprouting and the growth of injured
axons in the spinal cord. We find, however, that recovery of
forelimb dexterity is impaired in Sox11-treated animals. These
data show that CNS axon regeneration is limited in part by
insufficient activation of the Sox11 transcriptional program,
but also provide an illustrative example hinting that reinitiation of this program, in the absence of additional mechanisms
to properly sculpt axon function, can lead to functional
impairment.
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Materials and Methods
Cloning and virus construction
Adeno-associated virus pseudotype 8 (AAV8)enhanced blue fluorescent protein (EBFP)-2AmCherry and AAV8-EGFP have been previously
described (Blackmore et al., 2012). To generate
AAV8-Sox11-2A-mCherry, PCR-amplified
Sox11 (BC078643; OpenBiosystems) replaced
EBFP in the AAV-2A-mCherry plasmid using
Kpn1 and BamHI sites. Viral packaging was
performed at the Miami Project Viral Vector
Core. All titers were brought to 5 ⫻ 10 13/ml.
Sox11 expression was confirmed via immunohistochemistry on free-floating, paraformaldehyde-fixed tissue sections using goat
polyclonal anti-Sox11 (C-20, 1:300; Santa Cruz
Biotechnology).

Viral injections and injuries
All animal procedures were performed on 8- to
10-week-old female C57BL/6 mice (Harlan)
and approved by the Marquette University Institutional Animal Care and Use Committee.
DRG neurons were transduced by intrathecal
injection of 1 l of AAV (Parikh et al., 2011;
Schuster et al., 2013). Cortical neurons were
transduced by 0.5 l of AAV sterotactically injected to sensorimotor cortex (1.5 mm lateral,
0.5 mm anterior, 0.5 mm depth), as described
in the study by Blackmore et al. (2012). For
pyramidotomies, a ventral midline incision
was made, the occipital bone was exposed, and
the ventrocaudal part was removed using fine
rongeurs, the dura was punctured, and the
right pyramid was cut completely using a
micro-feather scalpel. For spinal injuries, animals were mounted into a custom spine stabilizer, the dorsal surface of the spinal cord was
exposed between C4/C5, and a lesion was made
to a depth of 0.85 mm, extending 1 mm to the
left of the midline and beyond the right edge of
the spinal cord, using a Vibraknife (Ping Zheng
and Christopher Shields, Norton Neurologicals, Louisville, KY) as reported previously
(Blackmore et al., 2012). Viral injections occurred 1 week after injury in the pyramidotomy experiment, 1 week before injury in the
first spinal injury experiment, and 8 weeks
postinjury in the chronic injury experiment.
To retrogradely label CST neurons, 1 l of
Choleratoxin B (CTB)-Alexa Fluor 647 was injected stereotactically via Hamilton syringe
into C4/C5 spinal cord, and to label ascending
DRG axons, Dextran 488 tracer (Invitrogen)
was injected into the sciatic nerve 7 d before the
mice were killed.

Histological assessment
Sagittal (spinal injury experiments) or transverse ( pyramidotomy) sections of spinal cord
were cut via vibratome, and immunohistochemistry analysis for PKC␥ (C-19, 1:500;
Santa Cruz Biotechnology) or GFAP (DAKO)
was performed. Exclusion criteria for pyramidotomy experiments was a ⬍80% decrease in
PKC␥ levels in the affected CST; for spinal injuries, exclusion criteria were as follows: (1)
lesion depth ⬍800 m; (2) axons with straight
white matter trajectory distal to the lesion; and

Figure 1. Sox11 overexpression reduces net retraction in centrally injured DRG axons. A, B, Cervical spinal cords 8 weeks after
dorsal injury (arrowheads) and 9 weeks after intrathecal delivery of AAV8-EBFP-2A-mCherry control (A) or AAV8-Sox11-2AmCherry (B). Viral transduction is confirmed by mCherry expression in DRG cell bodies (red, insets), and Sox11 expression is
confirmed by immunohistochemistry (blue, insets). Ascending DRG axons were labeled by dextran-Alexa Fluor 488 (green) to
visualize the position of injured axons (arrows) relative to the lesion center (arrowhead), outlined by GFAP immunoreactivity
(white). C, Quantification shows a significant reduction in the distance between the lesion center and the tip of the nearest injured
axon at both 5 d and 8 weeks postinjury in Sox11-treated animals. Scale bars: A, B, 200 m; insets, 50 m. N ⫽ 8 animals per
group, *p ⬍ 0.05, paired t test. Error bars show SEM.
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(3) EGFP ⫹ axons in thoracic cord (too far for regenerative growth).
EGFP ⫹ profiles that intersected virtual lines at set distances from the
center of the injury or the midline of the spinal cord were quantified by a
blinded observer on an Olympus IX81 microscope, then were normalized to total axons in transverse medullary sections (Blackmore et al.,
2012). TUNEL staining was performed on ethanol/acetic acid-treated cryostat sections of cortical tissue, 1 or 4 weeks postinjury and injection with
virus, or 2 d after administration of a staurosporine control (1 l, 1 mM;
Sigma) via In Situ Cell Death Kit (Roche) according to the instructions of the
manufacturer (Theus et al., 2014).

Behavioral assessment
Pellet retrieval. Animals were pretrained daily for 2 weeks to grasp and
retrieve a food pellet using the right forelimb through a displaced opening in a transparent cage (Farr and Whishaw, 2002). Inclusion criteria
were an average of 50% success (clear grasping and withdrawal, not
sweeping). Animals were tested postinjury in sessions consisting of 15
pellets or 10 min maximum; retrievals/attempts were quantified by a
blinded observer via video analysis.
Horizontal ladder. Animals were pretrained in two four-run sessions
on a horizontal ladder (30 cm long, 1 cm rung spacing), then were tested
after treatment in four-crossing sessions with the percentage of error
quantified on the last three runs. On the final test date, rung spacing was
made unequal by randomly removing rungs. Errors were defined as missteps or slips by the right forelimb.

Results

Figure 2. Sox11 is developmentally downregulated and is not re-expressed by spinally injured CST neurons. A, Sox11 (blue) is readily detected by immunohistochemistry in the embryonic cortex. B, C, Adult cortex 3 weeks after cortical injection of AAV8-EBFP (B) or AAV-Sox11
(C), and 2 weeks after cervical spinal injury and injection of retrograde CTB-647 (purple). Sox11
is not detected in injured cortex that received control virus (B) but is detected in the vicinity of
the AAV8-Sox11 injection (C). Scale bars: A–C, 500 m; insets, 20 m.

Sox11 is upregulated in DRG neurons after peripheral injury, but
not central injury, and overexpression of Sox11 accelerates peripheral nerve growth (Jing et al., 2012). A potential role for
Sox11 in CNS regeneration remains unexplored. We therefore
tested whether forced upregulation of Sox11 promotes regeneration in the central branch of DRG axons after spinal injury.
Sox11 or EBFP control was delivered to DRG neurons in vivo by
intrathecal AAV injection, with mCherry coexpressed using a 2A
peptide bridge, as described previously (Parikh et al., 2011; Blackmore et al., 2012). Two weeks later, mCherry expression confirmed a mean (⫾SEM) transduction of 51.9 ⫾ 4.6% of lumbar
DRG neurons (Fig. 1 A, B). Sox11 was not detected by immunohistochemistry in DRG neurons transduced with AAV-EBFP,
which is consistent with previous reports that central injury to
DRG neurons does not induce Sox11 expression (Fig. 1A;
Jankowski et al., 2009). In contrast, immunohistochemistry in
Sox11-treated DRGs showed strong expression of Sox11 protein
(Fig. 1 A, B), on par with its detection in embryonic neurons (Fig.
2A), demonstrating effective viral overexpression. Eight weeks
after C5 dorsal hemisection, neither control nor Sox11-treated
DRG neurons showed regeneration of axons distal to the injury
site (Fig. 1). Sox11-treated DRG axons, however, were significantly closer to the lesion center (EBFP, 463.9 ⫾ 117 m; Sox11,
177.7 ⫾ 21.5 m; p ⫽ 0.017, paired t test). A second experiment
showed similar results at 5 d postinjury (EBFP, 601 ⫾ 100.9 m;
Sox11, 260.5 ⫾ 21.5 m; p ⫽ 0.027, paired t test), suggesting that
Sox11 reduced the initial axonal retraction as opposed to facilitating regeneration. These data indicate that forced expression of
Sox11 in centrally injured DRG neurons alters their response to
injury in a manner that reduces net axonal dieback.
We next examined the role of Sox11 in the injury response of
CNS neurons, in which Sox11 is known to be expressed developmentally during periods of initial axon growth but is downregulated
with age (Penzo-Méndez, 2010). We delivered AAV8-Sox11-2AmCherry or AAV8-EBFP-2A-mCherry control to adult cortical
neurons by direct injection, and then performed C5 cervical hemisections (Blackmore et al., 2012). The tracer CTB-Alexa Fluor
647 was injected into the injury site to retrogradely identify CST
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Figure 3. Viral overexpression of Sox11 promotes the growth of injured CST axons. A–C, Transverse sections of cervical spinal cord 8 weeks after left pyramidotomy and right unilateral cortical
AAV injection. Sprouting across the midline (insets) is significantly elevated in Sox11-treated animals. D–F, Sagittal sections of cervical spinal cord 8 weeks postinjury and 9 weeks after cortical AAV
injection. GFAP reactivity (blue) indicates the injury site (arrowheads) and transduced CST axons are green. The number of EGFP ⫹ CST axons distal to the injury, normalized to the total number of
transduced CST axons quantified in transverse sections of the medullary pyramid (insets), is significantly elevated in Sox11-treated animals (arrows, E, and quantified in F ). G–I are similar to D and
E except viral treatment was delayed until 8 weeks postinjury. N ⱖ 8 animals per group. *p ⬍ 0.05, **p ⬍ 0.01, two-way repeated-measures ANOVA with Bonferroni’s post hoc correction. Scale
bars: A–I, 500 m; insets, 50 m. Error bars show SEM.

neurons. Two weeks later, immunohistochemistry detected
Sox11 expression in transduced (mCherry ⫹), retrogradely identified CST neurons (CTB-647 ⫹) treated with AAV-Sox11, but
not control AAV-EBFP (Fig. 2C,D). Sox11 was readily detectable
in embryonic cortex (Fig. 2 A, B). These data confirm a developmental downregulation of Sox11, show a lack of re-expression in
injured CST neurons, and demonstrate successful viral expression of Sox11 in CST neurons.
Is Sox11 expression sufficient to promote axonal growth in
injured CST neurons? To assess the effects on axon sprouting, we
performed a left pyramidotomy in adult mice and then injected
AAV-Sox11-2A-mCherry or EBFP-2A-mCherry into the right
sensorimotor cortex, along with AAV-EGFP as an axonal tracer
(Blackmore et al., 2012). This paradigm deprives the right half
of the spinal cord of CST input and assesses the ability of
uninjured left CST axons to extend collateral branches across
the midline into denervated territory. Successful pyramidotomy was confirmed by a more than fivefold reduction in PKC␥
immunoreactivity in the right CST (Materials and Methods;
Liu et al., 2010). Eight weeks after pyramidotomy, transverse
sections of cervical spinal cord were prepared. Sox11-treated
animals showed significantly more transduced (EGFP ⫹) CST
fibers crossing up to 600 m into the left spinal cord. (Fig.

3A–C). Thus, forced expression of Sox11 promotes compensatory sprouting by CST axons.
Next, we tested the effect of Sox11 on the growth of injured
CST axons. Sox11 or control virus was coinjected with EGFP
tracer to the left sensorimotor cortex, and right cervical dorsal
hemisections were performed. Eight weeks postinjury, Sox11injected animals showed a significantly greater number of
EGFP ⫹ CST axons up to 1 mm distal to the injury site (Fig.
3D–F ). In a second experiment, viral treatments were delayed 8
weeks after spinal injury, and then axon growth was quantified
after an additional 8 weeks. Again, although the effect appeared
reduced compared with the acute paradigm (Fig. 3F ), Sox11treated animals showed a significant elevation in CST axon
growth distal to the injury site compared with control animals
(Fig. 3G–I ). In both experiments, axons were observed circumventing the injury site but did not appear to grow across the
injury gap. In addition, the dystrophic end bulbs at the tips of the
main CST axons appeared unaffected by Sox11 treatment, and
the elevated growth appeared to arise from collateral branches of
CST axons. Combined, these data indicate that the overexpression of Sox11 in CST neurons promotes axon growth in the injured spinal cord, both in the short term and when applied 8
weeks postinjury.
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Figure 4. Viral overexpression of Sox11 in the cortex interferes with forelimb function after injury without affecting cell survival. A, B, Adult mice were subjected to pyramidotomy or spinal injury
and were cortically injected with AAV-EBFP control or AAV-Sox11, and then were tested weekly on a pellet retrieval task. Injury caused a persistent reduction in successful retrievals that was
unaffected by viral treatment ( p ⬎ 0.05, two-way repeated-measures ANOVA with Bonferroni’s post hoc correction). C, D, Mice received spinal injury, and 8 weeks later received cortical injection
of AAV-EBFP control of AAV-Sox11. Quantification of footfall errors by the right forelimb on a horizontal task revealed a significant reduction in accuracy in Sox11-treated animals that emerged 5
weeks after viral injection. *p ⬍ 0.05, two-way repeated-measures ANOVA with Bonferroni’s post hoc correction. E, Animals were tested 8 weeks after viral treatment on a horizontal ladder with
unevenly spaced rungs. Sox11-treated animals showed significantly reduced accuracy of forelimb placement in all three injury paradigms. N ⱖ 8 animals per group. *p ⬍ 0.05, paired t test. F–K,
Sox11-transduced cortical cells (F, H, red) display no TUNEL reactivity either 1 week (F, G) or 4 weeks (H, I ) after viral injection and cervical injury (G, I, arrows). J, As a control, staurosporine toxin
causes robust TUNEL signal (green). I, Quantification reveals no difference in TUNEL signal between EBFP- or Sox11-injected animals. N ⫽ 3 animals per group. *p ⬍ 0.05, ANOVA with Tukey’s HSD
test. Error bars show SEM.

The elevated axon growth observed in Sox11-expressing CST
neurons raised the question of whether these anatomical changes
are paralleled by improvements in forelimb function. Mice were
tested on a pellet retrieval task and a horizontal ladder task, both
of which reliably detect deficits in forelimb function after pyramidotomy or cervical spinal injury (Starkey et al., 2005; Shim et
al., 2012b). As expected, both pyramidotomy and spinal injury
dramatically reduced the rate of successful pellet retrieval (Fig.
4 A, B). In the 8 weeks following viral injection, performance in
both injury paradigms was similar in AAV-EBFP-treated and
AAV-Sox11-treated animals, suggesting that Sox11-induced CST
growth did not affect forelimb dexterity in this task. In the horizontal ladder task, injury produced a reliable increase in footslips
in the right forelimb (Fig. 4C–E). Unexpectedly, Sox11 treatment
resulted in an increased error rate compared with control animals. In the chronic injury experiment, the deficits in the Sox11treated animals emerged 4 weeks after viral injection (12 weeks
postinjury) and persisted for the duration of the experiment (Fig.
4D). Similarly, in the acute treatment paradigm and in the pyramidotomy experiment, Sox11-treated animals showed a significant elevation in footslips compared with controls when
confronted with unevenly spaced rungs (Fig. 4E). Importantly,
TUNEL assays in Sox11-treated cortex performed at 1 week
postinjection (the onset of viral expression) or at 4 weeks postinjection (the onset of behavioral deficits; Fig. 4D) showed no evidence for apoptosis (Fig. 4F–K ). Moreover, the average number
of transduced CST axons detected at 8 weeks postinjection in the
medullary pyramids (Fig. 3 D, E,G,H, insets) was not reduced in
Sox11-treated animals [Sox11 vs EBFP: acute spinal cord injury
(SCI), 1949 ⫾ 298 vs 1943 ⫾ 343; chronic SCI, 2470 ⫾ 711 vs
2577 ⫾ 452; pyramidotomy, 2289 ⫾ 209 vs 2532 ⫾ 345]. These

data demonstrate that the behavioral deficits were not secondary
to a reduction in cell survival or overt loss of CST axons. Combined with the histological data, these data show that the overexpression of Sox11 in CST neurons reliably promotes axon growth
across a range of injury paradigms, while also producing deficits
in forelimb dexterity.

Discussion
We found that Sox11, a transcription factor that is widely associated with examples of successful regeneration, is not upregulated
by DRG or CST neurons after spinal injury, and that forced expression is sufficient to enhance CNS axon growth. The effects in
DRGs were limited to a reduction in net axonal retraction, but
effects in CST neurons were more pronounced. Indeed, although
comparisons between experiments must be made cautiously, the
magnitude of the CST response, when normalized to the total
number of transduced CST axons, appears to be similar to that
reported previously for PTEN (phosphatase and tensin homolog)
knockout and overexpression of VP16-KLF7 (Liu et al., 2010;
Blackmore et al., 2012). AAV8-driven protein expression commences within a week of injection (Blackmore et al., 2012), so in
the first CST regeneration experiment exogenous Sox11 protein
was likely already present at the time of injury. Importantly, we
also show that Sox11 promotes CST growth even when delivered
2 months postinjury, showing that it can act independently of
intracellular and extracellular conditions that might be unique to
the acute injury response.
By what molecular mechanism might Sox11 be acting to promote axon growth? Although Sox11 is known to affect cell survival during early embryogenesis (Thein et al., 2010), we detected
almost no apoptosis in the cortex of spinally injured animals
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treated with either EBFP control or Sox11 virus (Fig. 4I; Nielson
et al., 2011). It is therefore unlikely that cell survival effects can
explain the enhanced sprouting in Sox11-treated animals. On the
other hand, regeneration-associated genes, including Sprr1a
(small proline-rich protein 1a), BDNF, and TANK (TRAF family
member-associated nuclear factor-B activator), have been identified as direct transcriptional targets of Sox11 in regenerating
DRG neurons (Jing et al., 2012; Salerno et al., 2012, 2013). These
data favor the possibility that Sox11 may similarly promote axon
growth in CST neurons by activating pro-regenerative genes.
Identifying genes that act downstream of Sox11 to promote
CST axon growth represents an important direction for future
research.
A striking finding of this work is that the overexpression of
Sox11 promotes CST axon growth while also reducing forelimb
dexterity. CST axons are known to participate in postinjury plasticity in the spinal cord by elongating collateral branches, engaging interneurons and propriospinal neurons, and ultimately
participating in novel circuitry (Bareyre et al., 2004; Carmel et al.,
2010; Hunanyan et al., 2013). This innate CST plasticity appears
to be behaviorally beneficial, as subsequent lesioning of CST axons abrogates endogenous recovery (Bareyre et al., 2004). In
other cases, however, plasticity in the CNS can be maladaptive.
For instance, endogenous remodeling of local spinal circuitry
after spinal injury contributes to neuronal dysfunction, and species that are capable of axon regeneration in the optic system can
remain functionally blind due to errors in topographic targeting
(Beazley et al., 2003; Beauparlant et al., 2013). In one intriguing
example of dysfunctional regeneration, axon growth across a cellular bridge in a transected spinal cord led to suppressed locomotor activity that was improved by retransection of the bridge
(Takeoka et al., 2011).
These examples illustrate a growing awareness that although
enhancing the regrowth or sprouting of axons after injury remains a major goal, the potential exists for both endogenous and
treatment-induced growth to be maladaptive, perhaps due to
errors in targeting. For instance, appropriate targeting of regenerated fibers is emerging as an important challenge in the optic
system (Luo et al., 2013; Pernet and Schwab, 2014). Interestingly,
previous interventions (Carmel et al., 2010; Wang et al., 2011) to
augment CST sprouting after injury such as cortical stimulation
or combined rehabilitative training and degradation of
growth-inhibiting chondroitin sulfate proteoglycans, have reported positive correlations between increased CST sprouting
and behavioral recovery. It remains unclear why Sox11-treated
animals showed reduced dexterity, but one speculative possibility
is that Sox11-stimulated CST axons may form or maintain erroneous connections in the absence of activity-dependent mechanisms to sculpt connectivity. Regardless, these findings highlight
the potential of a new gene-based manipulation to augment CST
growth after injury, while also highlighting the need for additional strategies to optimize not only the growth but the function
of regenerated axons.
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